Medable

Medable's Digital Clinical Trial Platform

Medable offers a comprehensive digital clinical trial platform designed to streamline and accelerate the clinical trial process. The platform includes advanced features such as eConsent, TeleVisit, eCOA (electronic Clinical Outcome Assessment), and remote monitoring. These tools are crucial in enhancing patient engagement and data collection, ultimately speeding up the trial process and improving data accuracy. Medable’s platform is utilized by a range of clients including mid to large pharmaceutical companies, emerging biopharma firms, and Contract Research Organizations (CROs). By leveraging Medable’s technology, these organizations can conduct more efficient and effective clinical trials.

Medable's Therapeutic Area Solutions

Medable provides specialized solutions tailored to specific therapeutic areas such as Oncology and Vaccine development. These tailored solutions address the unique challenges and requirements of these fields, ensuring that clinical trials are optimized for the best possible outcomes. In oncology, for example, the platform's remote monitoring and TeleVisit capabilities allow for continuous patient observation without requiring frequent hospital visits, which is crucial for patients undergoing intensive treatments. Similarly, in vaccine development, Medable’s platform supports rapid and large-scale eConsent and data collection, which are essential for timely vaccine trials.

Medable's Global Reach and Compliance

Medable’s platform supports clinical trials in over 60 countries and is available in over 120 languages, making it a truly global solution. The platform’s extensive language support ensures that trials can be conducted inclusively, catering to diverse patient populations around the world. Moreover, Medable complies with stringent global regulations including FDA 21 CFR Part 11, HIPAA, and GDPR, ensuring that data privacy and security standards are upheld. This compliance is critical for gaining the trust of regulatory bodies and patients alike, facilitating smoother and more widely accepted clinical trial processes.

Medable's eConsent Adoption Success

Medable has achieved significant success in the adoption of its eConsent feature, particularly highlighted by its 75% eConsent adoption rate among elderly patients in a U.S. Renal Care clinical trial. This high adoption rate demonstrates the platform’s user-friendly design and its effectiveness in engaging a demographic that typically faces challenges with digital tools. The successful implementation of eConsent in such trials not only improves patient compliance but also enhances the accuracy and efficiency of the consent process, which is a critical component of clinical trials.

Medable's Awards and Recognition

In recognition of its innovative contributions to digital health, Medable won the 2023 Prix Galien Award for Best Digital Health Solution. This prestigious award acknowledges Medable’s excellence in providing a platform that significantly improves the clinical trial process. The Prix Galien Award is known for honoring outstanding achievements that benefit human health, and Medable’s receipt of this award underscores its leadership and pioneering efforts in the digital health space. Such accolades not only enhance Medable’s reputation but also highlight the transformative impact of its solutions on the healthcare industry.